|
SEPTEMBER 21-22, 2026 | NATIONAL HARBOR, MD |
Securing the U.S. Bioeconomy: A Leadership Summit
From Fragmentation to Force: Aligning Capital, Policy, and Industrial Capacity
The bioeconomy is increasingly constrained by execution at scale.
The United States leads in industrial biotechnology discovery and early innovation but has struggled to consistently translate that advantage into deployed, commercial capacity. Projects stall between pilot and production, constrained by infrastructure, financing, supply chain fragmentation, and inconsistent demand signals.
This Summit brings together the leaders positioned to change that outcome: those building facilities, financing infrastructure, shaping procurement, and working to turn fragmented capability into functioning industry.
The question is no longer what is possible in the lab, rather, "what can be built, financed, and operated at commercial scale before global competitors lock in industrial-scale capacity?"
Who Should Attend?
Leaders directly involved in building, financing, and deploying bioindustrial capacity:
- Industrial biotech executives scaling to commercial production
- Investors financing first-of-a-kind and new deployment models
- Federal leaders overseeing funding, infrastructure, and procurement
- Experts in regulation and industrial strategy
- Defense stakeholders in domestic manufacturing and supply chains
- Corporate partners shaping demand and off take
- Developers, operators, and platform builders deploying capacity at scale
- Scale-up and technical leaders driving time-to-scale and cost parity
This Summit is focused on execution.
- Align capital, industry, and government on near-term deployment priorities
- Define demand signaling, procurement, and partnership models that can be implemented now
- Pinpoint where federal coordination and regulatory changes can accelerate deployment
- Expose critical vulnerabilities in supply chains and biomanufacturing capacity
- Catalyze partnerships and establish clear next steps for executionÂ
Industrial Biotech Innovation Prize Challenge
Join us for a pitch competition featuring emerging technologies driving scalable bioindustrial solutions.
- Ten (10) finalists
- Breakthrough approaches across biomanufacturing, materials, and bio-based production
- Review panelists including investors, industry partners, and government stakeholders
- $50,000 in non-dilutive prizes
Challenge Contact: Laura Murphree, laura@techconnect.org
Presented by | Powered by |
In collaboration with
